Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JTECTSE:3446 -2.19%64 OCF Margin % is 8.61% as of Jun. 2026, which is 5% below its 10-year median of 9.09. GuruFocus rates TSE:3446 with a GF Score™ of 64/100 and a GF Value™ of 円1,801.44 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, JTEC ranks worse than 51.29% on this metric.
OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. JTEC's Cash Flow from Operations for the
three
months ended in Jun. 2026 was 円79 Mil. JTEC's Revenue for the
three
months ended in Jun. 2026 was 円915 Mil. Therefore, JTEC's OCF Margin % for the quarter that ended in Jun. 2026 was 8.61%.
The historical rank and industry rank for JTEC's OCF Margin % or its related term are showing as below:
TSE:3446'
s OCF Margin % Range Over the Past 10 Years
Min: 3.12 Med: 9.09 Max: 26.32
Current: 6.13
During the past 10 years, the highest OCF Margin % of JTEC was 26.32%. The lowest was 3.12%. And the median was 9.09%.
TSE:3446's OCF Margin % is ranked worse than 51.29% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 6.69
vs TSE:3446: 6.13
The historical data trend for JTEC's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3446 vs ISRG, BDX, RMD: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, JTEC's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JTEC OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JTEC's OCF Margin % distribution charts can be found below:
* The bar in red indicates where JTEC's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JTEC (TSE:3446) has a OCF Margin % of 8.61% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on JTEC and its competitors. This is near median its historical median of 9.09. Over the past decade, JTEC's OCF Margin % has ranged from 3.12 to 26.32. According to the industry distribution chart, JTEC ranks #418 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 51.3%.
Is JTEC's OCF Margin % too high?
JTEC's current OCF Margin % of 8.61% is near median its 10-year median of 9.09. Over the past 10 years, this metric has ranged from a low of 3.12 to a high of 26.32. The Medical Devices & Instruments industry median OCF Margin % is 6.69. JTEC's value of 8.61% is 28.7% above this industry median. Based on the distribution chart, JTEC ranks #418 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, JTEC has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JTEC's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JTEC ranks #418 out of 815 companies for OCF Margin %. This places JTEC in the lower half of its industry. The industry median OCF Margin % is 6.69. JTEC's value of 8.61% is 28.7% above this benchmark. Historically, JTEC's own OCF Margin % has ranged from 3.12 to 26.32 over the past decade. While the company's 10-year median is 9.09 vs. the industry median of 6.69, JTEC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 6.69, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JTEC's current OCF Margin % of 8.61% is 28.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on JTEC and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 6.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JTEC's current OCF Margin % is 8.61%, which is near median its own 10-year median of 9.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JTEC stock overvalued right now?
Based on GuruFocus' analysis, JTEC (TSE:3446) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,801.44, compared to a current price of 円1,607.00 — trading 10.8% below its estimated fair value. The current OCF Margin % is 8.61%, which is near median its 10-year median of 9.09 and 28.7% above the Medical Devices & Instruments industry median of 6.69. JTEC's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For JTEC (TSE:3446), the current OCF Margin % is 8.61% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JTEC (TSE:3446) Overvalued in 2026?
Based on GuruFocus' analysis, JTEC stock appears to be undervalued.
The current stock price of 円1,607.00 is trading 10.8% below its estimated GF Value™ of 円1,801.44.
GuruFocus considers JTEC to be Modestly Undervalued.
Key valuation signals for TSE:3446:
OCF Margin %: 8.61% (near median its 10-year median of 9.09)
GF Value™: 円1,801.44 vs. price of 円1,607.00 (10.8% below fair value)
Industry Position: 28.7% above the Medical Devices & Instruments median (#418 of 815)
No single metric tells the full story. See the TSE:3446 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JTEC Corp is engaged in developing, designing, manufacturing and sales of Automated Cell Culture System; X-ray Mirrors for Synchrotron Facilities; and Automated System in various fields. Its products in optical business include Kirkpatrick-Baez (KB) mirror, Advanced KB mirror (1D Wolter mirror), Montel mirror, Ellipsoidal mirror, 2D Walter mirror, Deformable mirror, Multi-channel mirror, X-ray focusing alignment system (JM1000 / 2000 series), Additional mirror shaping improvement, and Mirror coating. Its products in life science include CELLFLOAT products and Automated Cell Culture Systems.
64GF Score
Get the complete analysis for TSE:3446
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3446 has been successfully added to your 
